Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling
-
Published:2024-06
Issue:6
Volume:6
Page:e331-e333
-
ISSN:2665-9913
-
Container-title:The Lancet Rheumatology
-
language:en
-
Short-container-title:The Lancet Rheumatology
Reference10 articles.
1. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
2. Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial;Park;Lancet Rheumatol,2024
3. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study;Chlibek;Vaccine,2014
4. Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older;Cunningham;J Infect Dis,2018
5. Influenza, pneumococcal and herpes zoster vaccination rates in patients with autoimmune inflammatory rheumatic diseases;Krasselt;Vaccines (Basel),2023